Trade ProPhase Labs, Inc. - PRPH CFD
Add to favourite- Summary
- Historical Data
Spread | 0.12 | ||||||||
Long position overnight fee
Long position overnight fee
Go to platform | -0.026179% | ||||||||
Short position overnight fee
Short position overnight fee
Go to platform | 0.003957% | ||||||||
Overnight fee time | 21:00 (UTC) | ||||||||
Min traded quantity | 1 | ||||||||
Currency | USD | ||||||||
Margin | 5% | ||||||||
Stock exchange | United States of America | ||||||||
Commission on trade | 0% |
Prev. Close | 4.52 |
Open | 4.54 |
1-Year Change | -39.3% |
Day's Range | 4.54 - 5.13 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | Close | Change | Change (%) | Open | High | Low |
---|---|---|---|---|---|---|
May 1, 2024 | 5.09 | 0.55 | 12.11% | 4.54 | 5.28 | 4.54 |
Apr 30, 2024 | 4.52 | -0.04 | -0.88% | 4.56 | 4.64 | 4.42 |
Apr 29, 2024 | 4.59 | -0.14 | -2.96% | 4.73 | 4.75 | 4.56 |
Apr 26, 2024 | 4.69 | -0.17 | -3.50% | 4.86 | 4.86 | 4.56 |
Apr 25, 2024 | 4.93 | -0.05 | -1.00% | 4.98 | 5.04 | 4.86 |
Apr 24, 2024 | 5.04 | -0.10 | -1.95% | 5.14 | 5.19 | 5.00 |
Apr 23, 2024 | 5.14 | 0.27 | 5.54% | 4.87 | 5.26 | 4.86 |
Apr 22, 2024 | 4.89 | -0.24 | -4.68% | 5.13 | 5.13 | 4.86 |
Apr 19, 2024 | 5.16 | -0.07 | -1.34% | 5.23 | 5.28 | 5.03 |
Apr 18, 2024 | 5.38 | -0.85 | -13.64% | 6.23 | 6.23 | 5.23 |
Apr 17, 2024 | 6.14 | -1.18 | -16.12% | 7.32 | 7.36 | 5.98 |
Apr 16, 2024 | 7.34 | 0.97 | 15.23% | 6.37 | 7.44 | 6.22 |
Apr 15, 2024 | 6.10 | -0.44 | -6.73% | 6.54 | 6.61 | 6.02 |
Apr 12, 2024 | 6.33 | -0.05 | -0.78% | 6.38 | 6.58 | 6.29 |
Apr 11, 2024 | 6.36 | -0.27 | -4.07% | 6.63 | 6.63 | 6.18 |
Apr 10, 2024 | 6.11 | 0.12 | 2.00% | 5.99 | 6.18 | 5.98 |
Apr 9, 2024 | 6.07 | -0.41 | -6.33% | 6.48 | 6.58 | 6.03 |
Apr 8, 2024 | 6.58 | -0.20 | -2.95% | 6.78 | 6.81 | 6.48 |
Apr 5, 2024 | 6.78 | 0.30 | 4.63% | 6.48 | 6.85 | 6.48 |
Apr 4, 2024 | 6.53 | -0.04 | -0.61% | 6.57 | 6.60 | 6.49 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
ProPhase Labs, Inc. Company profile
About ProPhase Labs Inc
ProPhase Labs, Inc. is a medical science and technology company. The Company operates through two segments: consumer products and diagnostic services. The consumer products segment is engaged in the research, development, manufacture, distribution, marketing and sale of over-the-counter (OTC) consumer healthcare products and dietary supplements in the United States. The diagnostic services segment provides COVID-19 diagnostic information services to a range of customers in the United States, including health plans, third party payers and government organizations. The Company is also engaged in development and distribution of a product line of OTC dietary supplements under the brand name of TK Supplements. The TK Supplements product line offers two men’s health products, including Legendz XL for sexual health and Triple Edge XL, an energy booster plus testosterone support.
Financial summary
BRIEF: For the nine months ended 30 September 2021, ProPhase Labs Inc revenues increased from $9.4M to $33.9M. Net loss before extraordinary items increased from $1.3M to $4.3M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Higher net loss reflects General and administration increase from $3.3M to $14.7M (expense).
Equity composition
Common Stock $.0005 Par, 12/10, 50M auth., 19,353,672 issd., less 4,646,053 shs. in Treas. @ $25.2M. Insiders & Stakeholder owns 43.95%. PO 2/91, 3M shares @ $.15 by Concorde Brokerage Corporation. 1/97, 2-for-1 stock split. FY '00 '01 fins. are RES due to disc. opr. Sum Qs reflect restated EPS. FY '02 Qs are restated for disc. opr.
Industry: | Special Foods & Wellbeing Products |
711 Stewart Ave, Suite 200
Garden City
NEW YORK
NEW YORK 11530
US
News
We’re partnering with Newsquawk
Filter out the noise and focus on the news that matters.
08:32, 23 April 2024US Earnings Season: Tesla, Alphabet, Meta Platforms and Microsoft
The first lot of Wall Street’s mega-cap tech companies report in the coming week. We preview what to expect from Tesla, Alphabet, Meta, and Microsoft’s quarterly results.
15:56, 22 April 2024Gold price in 2024: geopolitical tensions and rate-cut expectations keep XAU/USD supported
Investors are keeping a close eye on gold as the conflict in the Middle East escalates with a possibility of a full-scale regional war in the area.
07:56, 17 April 2024US Earnings Season : JP Morgan, Citigroup, Wells Fargo
The first major US banks report quarterly earnings on Friday, April 12th, 2024. We preview what to expect from JP Morgan, Citigroup, and Wells Fargo's quarterly numbers.
16:03, 11 April 2024Reserve Bank of New Zealand Preview: Rates expected to remain on hold as inflation fight continues
The Reserve Bank of New Zealand (RBNZ) meets on Wednesday, April 10, 2024. We preview what to expect from the meeting and its possible impact on the NZD/USD.
09:22, 11 April 2024US CPI Preview: US inflation expected to grind lower amid fears about sticky prices
US CPI data is released on Wednesday, 10 April. We preview what to expect from the data, how it could influence US Federal Reserve policy, and analyse the NASDAQ (US Tech 100).
15:11, 9 April 2024How escalating geopolitical tensions are impacting oil markets
The bullish momentum in oil prices remains strong as escalating geopolitical tensions raise concerns about supply.
13:34, 4 April 2024People also watch
Still looking for a broker you can trust?
Join the 610,000+ traders worldwide that chose to trade with Capital.com